Alex Pearson

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 712 citations · Full text

Endocrine Oncology, Breast Oncology, Endocrine-related Cancer +14

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Nicholas C. Turner, Maryou B. Lambros, Hugo M. Horlings et al. · Oncogene · 2010 · 405 citations · Full text

Breast Oncology, Functional Genomics, Potential Therapeutic Targets +11

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 259 citations · Full text

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer

Neha Chopra, Holly Tovey, Alex Pearson et al. · Nature Communications · 2020 · 252 citations · Full text

FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both <i>In Vitro</i> and <i>In Vivo</i>

Rachel Sharpe, Alex Pearson, María Teresa Herrera-Abreu et al. · Clinical Cancer Research · 2011 · 165 citations · Full text